Showing results (1181-1190 of 1,191) with videos related to
Sort By:
Pageof 120
Clinical Kidney Journal|February 10, 2025
Multiethnic prevalence of the <i>APOL1</i> G1 and G2 variants among the Israeli dialysis populationDror Ben-Ruby, Danit Atias-Varon, Maayan Kagan, et al.Nature Methods|July 9, 2021
Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practicesSaleh Alseekh, Asaph Aharoni, Yariv Brotman, et al.Cell|September 18, 2012
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanomaChristine Guo Lian, Yufei Xu, Craig Ceol, et al.The Oncologist|July 21, 2021
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma TestingWael Al Zoughbi, Jesse Fox, Shaham Beg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2024
Linvoseltamab for Treatment of Relapsed/Refractory Multiple MyelomaNaresh Bumma, Joshua Richter, Sundar Jagannath, et al.Cancer Discovery|January 9, 2021
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1<sup>+</sup> Activated T CellsSimon J Dovedi, Matthew J Elder, Chunning Yang, et al.Nature Genetics|August 14, 2019
Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancerSahar Nissim, Ignaty Leshchiner, Joseph D Mancias, et al.Cancer Research|September 9, 2022
An Exercise-Induced Metabolic Shield in Distant Organs Blocks Cancer Progression and Metastatic DisseminationDanna Sheinboim, Shivang Parikh, Paulee Manich, et al.Cell|April 3, 2025
Therapeutic potential of allosteric HECT E3 ligase inhibitionAlexander M K Rothman, Amir Florentin, Florence Zink, et al.Nature|November 30, 2022
Common and rare variant associations with clonal haematopoiesis phenotypesMichael D Kessler, Amy Damask, Sean O'Keeffe, et al.Pageof 120